Local Institution - 0233

Shinjuku-ku, Tokyo 160-0023

1 studies enrolling now · 1 studies all time

What they study most

Breast Neoplasms

Studies at this site

• A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) — Recruiting now